RL15 RL15 Pill - white & yellow capsule/oblong, 14mm
Pill with imprint RL15 RL15 is White & Yellow, Capsule/Oblong and has been identified as Metoprolol Succinate Extended-Release 50 mg. It is supplied by Ohm Laboratories Inc.
Metoprolol is used in the treatment of Heart Failure; Angina; High Blood Pressure; Angina Pectoris Prophylaxis; Heart Attack and belongs to the drug class cardioselective beta blockers. Risk cannot be ruled out during pregnancy. Metoprolol 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RL15 RL15
Metoprolol Succinate Extended-Release
- Imprint
- RL15 RL15
- Strength
- 50 mg
- Color
- White & Yellow
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Cardioselective beta blockers
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ohm Laboratories Inc.
- National Drug Code (NDC)
- 63304-0009
- Inactive Ingredients
-
hypromellose 2910 (5 mPa.s),
ethylcellulose (20 mPa.s),
polyethylene glycol 400,
polyethylene glycol 6000,
sucrose,
corn starch,
magnesium silicate,
triethyl citrate,
ferric oxide yellow,
ferrosoferric oxide,
potassium hydroxide,
propylene glycol,
shellac,
titanium dioxide
Note: Inactive ingredients may vary.
Related images for "RL15 RL15"
More about metoprolol
- Check interactions
- Compare alternatives
- Reviews (653)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: cardioselective beta blockers
- Breastfeeding
- En español
Patient resources
- Metoprolol drug information
- Metoprolol (Intravenous) (Advanced Reading)
- Metoprolol Extended-Release Tablets
Other brands
Professional resources
- Metoprolol monograph
- Metoprolol (FDA)
- Metoprolol Succinate (FDA)
- Metoprolol Succinate ER Capsules (FDA)
- Metoprolol Succinate ER Tablets (FDA)
Other brands
Toprol-XL, Lopressor, Kapspargo Sprinkle
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.